Skip to main content
Caplight Logo









PYM

PYM

Private
CaliforniaHealthcare & Life Scienceshttps://youcanpym.com

Last Round

Angel

Oct 27, 2020

Total Funding Raised

$1M

Company Overview

PYM operates in Healthcare & Life Sciences and is based in California. Its latest recorded funding round was an Angel round in October 2020.

PYM is a food products company that produces all-natural, amino acid-based chewable supplements and mental wellness products designed to support stress management and neurotransmitter health.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PYM Comparables

Compare PYM with similar companies based on industry and business-model similarity.

PYM comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
R3SET
86%
Moon Juice
83%
Avantera Health
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PYM Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelOct 27, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Erica Berthold

CEO

Executive Team

Sanjay Lamba

Advisor To Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

PYM Investors

Notable investors and investment history

PYM investors
InvestorRounds
Animal CapitalAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 82% MoM to 32.7K.

  • Jan 20, 2026

    Monthly visitors increased 30% MoM, reaching 24.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

PYM Filings

Explore SEC and related filing metadata, where available.

PYM filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PYM's valuation, stock price, and market status.

Is PYM a public or private company?

PYM is a private company.

What is the current stock price of PYM?

PYM is a private company, so its shares have no public market price. Caplight tracks PYM's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PYM worth (valuation)?

Valuation information for PYM is not publicly available.

Can I buy PYM stock?

PYM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PYM's last funding round?

PYM's most recent funding round was Angel on October 27, 2020.

Who are the main investors in PYM?

Key investors in PYM include Animal Capital.

Will PYM IPO soon?

No public IPO plans have been announced for PYM.

How can I track PYM secondary market activity?

Caplight tracks bids, offers, and trades in PYM's shares on secondary markets.

Firmographic Details

HeadquartersCalifornia
Employee Range14
Year Founded2019
Last FundingOct 27, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?